Skip to Main content Skip to Navigation
Patents

Use of Compounds inhibiting apelin / AJP / GP130 signaling for treating Cancer

Julie Gavard 1 
1 CRCINA-ÉQUIPE 15 - Signaling in Oncogenesis, Angiogenesis and Permeability
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
Document type :
Patents
Complete list of metadata

https://www.hal.inserm.fr/inserm-02541583
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Tuesday, April 14, 2020 - 8:27:23 AM
Last modification on : Wednesday, April 27, 2022 - 4:21:49 AM

Identifiers

  • HAL Id : inserm-02541583, version 1

Citation

Julie Gavard. Use of Compounds inhibiting apelin / AJP / GP130 signaling for treating Cancer. United States, Patent n° : US 10247722 B2. 2019. ⟨inserm-02541583⟩

Share

Metrics

Record views

18